On this page
What is Mitral Valve Regurgitation?
Mitral valve regurgitation (also called mitral insufficiency or mitral incompetence) is the most common form of heart valve disease. It occurs when the mitral valve, which is the valve separating the left atrium from the left ventricle, fails to close completely during each heartbeat. This allows oxygenated blood to flow backward (regurgitate) from the left ventricle into the left atrium instead of being pumped efficiently out to the body through the aorta.
Because the mitral valve is not sealing properly, a portion of the blood ejected by the heart leaks in the wrong direction with every beat, reducing the volume of oxygen-rich blood available to the body’s organs and tissues.
Mitral regurgitation is typically detected by a physician as a systolic heart murmur, which is an abnormal sound heard through a stethoscope during the pumping phase of the heartbeat.
A Condition That Can Hide for Years
One of the defining features of mitral valve regurgitation is that it can remain silent for many years. The degree to which the condition causes symptoms depends on two key factors:
- Severity: How much blood leaks backward with each heartbeat.
- Rate of progression: A slowly developing leak gives the heart and body time to compensate; the heart gradually enlarges and works harder to maintain adequate output, masking the problem until compensation mechanisms are eventually overwhelmed.
When Symptoms Do Appear
When mitral regurgitation becomes significant, symptoms may include:
- Shortness of breath and breathlessness (especially with exertion)
- Easy fatigue
- Palpitations (awareness of a rapid or irregular heartbeat)
- Swelling of the lower limbs (ankles and feet)
Treatment Overview
Treatment depends on the severity of regurgitation and the patient’s overall health:
- Mild cases often require only regular monitoring (watchful waiting) and no immediate intervention.
- Severe cases may require cardiac surgery to repair or replace the faulty mitral valve.
Causes
The mitral valve separates the left atrium from the left ventricle, the chamber responsible for pumping oxygenated blood out to the entire body through the aorta. For efficient cardiac output, this valve must form a tight seal during ventricular contraction.
When the seal is imperfect, oxygenated blood flows backward into the atrium, reducing the amount available to peripheral tissues and organs.
Common Causes of Mitral Valve Regurgitation
The causes of mitral regurgitation are diverse and include both structural and functional abnormalities:
- Mitral valve prolapse and other structural valve defects: the most common cause in developed countries, where one or both leaflets bulge into the left atrium during contraction
- Coronary artery disease and high blood pressure (hypertension): can damage or distort the valve apparatus over time
- Infective endocarditis: bacterial infection of the valve leaflets can destroy tissue and cause acute regurgitation
- Rheumatic heart disease: a complication of untreated streptococcal infections leading to rheumatic fever, which can scar and deform valve leaflets
- Hypertrophic cardiomyopathy: abnormal thickening of the heart muscle can impair valve function
- Congenital heart defects: structural abnormalities present from birth
- Rare systemic conditions: such as untreated syphilis or Marfan syndrome (a connective tissue disorder affecting the valve leaflets and supporting structures)
- Atrial fibrillation: chronic atrial fibrillation can cause the left atrium and mitral annulus to dilate, impairing valve closure
- Thoracic radiation therapy: prior chest radiation (e.g., for cancer treatment) can damage heart valves
- Long-term use of certain antimigraine medications (e.g., ergotamine derivatives): associated with fibrotic valve changes
Acute Mitral Regurgitation
Mitral regurgitation can also develop suddenly and dramatically rather than gradually. Causes of acute onset include:
- Myocardial infarction (heart attack): rupture of the papillary muscles (which anchor the valve leaflets) is a serious post-infarction complication
- Chest trauma: physical injury to the valve or its supporting structures
- Spontaneous chordae tendineae rupture: the thin tendons holding the valve leaflets can snap, even in the absence of prior disease
Acute mitral regurgitation is a medical emergency, as the heart has no time to compensate and patients can rapidly develop pulmonary edema and cardiogenic shock.
Symptoms
In chronic mitral regurgitation, the slow development of the leak allows the heart to adapt. The left ventricle dilates and becomes more powerful, and the left atrium enlarges to accommodate the regurgitant volume. This compensatory phase can last for years or even decades without noticeable symptoms.
However, when compensation mechanisms are exhausted, oxygenated blood delivery to the body becomes insufficient, and symptoms emerge:
Respiratory Symptoms
- Shortness of breath (dyspnea): initially only during physical exertion, progressively occurring also at rest
- Orthopnea: difficulty breathing when lying flat (patients may need to sleep propped up with multiple pillows)
- Increased breathing rate (tachypnea)
- Cough: especially at night or when lying down (a sign of pulmonary congestion)
Cardiovascular Symptoms
- Palpitations and tachycardia: awareness of a fast, fluttering, or irregular heartbeat, often a sign of developing atrial fibrillation
- Easy fatiguability: even with mild physical activity
- Dizziness and lightheadedness
Signs of Fluid Retention
- Water retention in the legs: swelling (edema) of the ankles, feet, and lower legs, a sign of right heart involvement or advanced heart failure
Important: The absence of symptoms does not mean the condition is not progressing. Regular cardiological follow-up is essential even in asymptomatic patients with known mitral regurgitation.
Complications
If left untreated or poorly managed, mitral valve regurgitation can lead to serious, potentially life-threatening complications:
Congestive Heart Failure
Over time, the heart’s compensatory mechanisms, particularly the continuous overwork of the left ventricle, eventually fail. The result is congestive heart failure: the heart can no longer pump enough blood to meet the body’s demands, leading to fluid buildup in the lungs, legs, and abdomen.
Atrial Fibrillation
Chronic enlargement of the left atrium (due to the increased volume of regurgitant blood) creates an electrical substrate for atrial fibrillation: a chaotic, irregular heart rhythm. This is a major complication because:
- It worsens cardiac output
- It significantly increases the risk of blood clot formation (thrombophilia) in the atrium, with subsequent risk of stroke or systemic embolism
Pulmonary Hypertension
As pressure builds up in the left atrium (due to the regurgitant blood), it is transmitted backward into the pulmonary circulation. This can cause pulmonary hypertension: elevated blood pressure in the arteries of the lungs, which over time can damage the right side of the heart and lead to right heart failure.
Left Ventricular Dysfunction
Despite initially appearing to function normally (or even hyperactively), the chronically overloaded left ventricle can suffer irreversible myocardial damage and loss of contractile function. This is why timing of surgical intervention is critical: operating before the ventricle is permanently damaged leads to far better outcomes.
Diagnosis
The diagnosis and management of mitral valve regurgitation is primarily handled by a cardiologist, with a cardiac surgeon involved when surgical intervention is being considered.
Clinical Examination
The first clue is often the characteristic systolic murmur audible through a stethoscope during the cardiac examination: a blowing, high-pitched sound best heard at the apex of the heart, often radiating to the axilla. Additional physical findings that may indicate significant regurgitation include:
- Lower limb edema (swelling of the ankles and lower legs)
- Hepatomegaly (enlargement of the liver, indicating elevated venous pressure)
- Jugular venous distension (engorgement of the neck veins, a sign of elevated right heart pressures)
Diagnostic Tests
A series of investigations is used to confirm the diagnosis, assess severity, and guide management decisions:
| Test | Purpose |
|---|---|
| Echocardiogram | Gold standard: uses ultrasound to visualize valve structure, quantify the degree of regurgitation, assess left ventricular size and function, and detect other abnormalities. Transesophageal echocardiography (TEE) provides even greater detail. |
| Electrocardiogram (ECG) | Detects arrhythmias (particularly atrial fibrillation) and signs of chamber enlargement |
| Chest X-ray | May reveal enlargement of the left atrium or ventricle, or signs of pulmonary congestion |
| Cardiac MRI | Provides highly accurate measurement of regurgitant volume and ventricular function |
| CT scan | Useful for pre-surgical planning, especially for transcatheter procedures |
| Stress testing | Helps evaluate exercise tolerance and unmask symptoms in apparently asymptomatic patients |
| Cardiac catheterization | Occasionally used to confirm hemodynamic severity or assess coronary artery disease before surgery |
Treatment
The management of mitral valve regurgitation is individualized and depends on the severity of regurgitation, the presence and degree of symptoms, left ventricular size and function, and the patient’s overall health status.
Watchful Waiting (Mild to Moderate Regurgitation)
Many patients with mild or moderate mitral regurgitation and no symptoms, preserved cardiac function, and no signs of complications do not require active treatment. Instead, they are managed with:
- Regular cardiological follow-up (typically every 6–12 months with echocardiographic assessment)
- Treatment of contributing conditions (e.g., hypertension, coronary artery disease)
Medical Therapy
Medications cannot repair or reverse the structural valve problem, but they can control symptoms, reduce cardiovascular strain, and manage associated conditions:
- Beta-blockers: slow the heart rate, reduce myocardial oxygen demand, and help control symptoms
- ACE inhibitors / ARBs: reduce afterload (the resistance against which the heart pumps), helping to decrease the regurgitant fraction and protect the ventricle
- Calcium channel blockers: used for rate control in atrial fibrillation or to reduce blood pressure
- Anticoagulants (e.g., warfarin, direct oral anticoagulants): essential in patients with atrial fibrillation to prevent thromboembolic events (stroke)
- Antiarrhythmic drugs: to manage atrial fibrillation or other rhythm disturbances
- Diuretics: reduce fluid overload and relieve symptoms of pulmonary congestion and peripheral edema
Surgical and Interventional Treatment
Surgery becomes necessary when:
- The left ventricle is significantly enlarged or its function is impaired (even without symptoms), because operating before irreversible damage is critical
- Symptoms are severe and cannot be adequately controlled with medications
- Significant complications (such as new-onset atrial fibrillation or pulmonary hypertension) develop
There are two main surgical approaches:
1. Mitral Valve Repair
This is the preferred option when technically feasible. The surgeon reconstructs the patient’s own valve, restoring its normal function. Advantages include:
- Better long-term survival
- Preserved left ventricular function
- No need for lifelong anticoagulation (unless atrial fibrillation is present)
- Lower risk of endocarditis
2. Mitral Valve Replacement
When repair is not possible (due to extensive valve damage), the diseased valve is replaced with:
- A mechanical prosthesis (durable but requires lifelong anticoagulation with warfarin)
- A biological (tissue) prosthesis (does not require long-term anticoagulation but has a limited lifespan and may need re-intervention)
3. Transcatheter Approaches (MitraClip)
For patients at high surgical risk, minimally invasive catheter-based procedures, such as the MitraClip (transcatheter edge-to-edge repair), offer an alternative. A clip is delivered via a catheter through a vein, grasping and approximating the valve leaflets to reduce regurgitation. This approach is increasingly used in elderly or frail patients with functional mitral regurgitation.
Lifestyle Changes
Lifestyle modifications play an important complementary role in managing mitral valve regurgitation, particularly in early-stage disease. Patients are generally advised to:
- Stop smoking: smoking accelerates cardiovascular disease progression and worsens outcomes across all heart conditions
- Achieve and maintain a healthy weight: excess weight increases the workload on the heart; check your BMI
- Follow a heart-healthy diet: rich in fruits, vegetables, whole grains, and legumes (such as the Mediterranean diet or the DASH diet), and low in sodium (salt restriction helps reduce fluid retention)
- Limit or eliminate alcohol consumption: alcohol can worsen arrhythmias and heart muscle function
- Exercise regularly: moderate aerobic exercise (such as walking, cycling, or swimming) is generally safe and beneficial for most patients with mild-to-moderate regurgitation; intensity should be guided by the cardiologist based on disease severity
- Monitor and control blood pressure: hypertension worsens regurgitation and accelerates disease progression
Note for patients: Always consult your cardiologist before starting a new exercise program or making significant changes to your diet or medications. The appropriate level of physical activity depends on the severity of your condition.
Sources and Bibliography
- Mount Sinai Health Library – Mitral Valve Regurgitation
- Mayo Clinic – Mitral Valve Regurgitation: Diagnosis & Treatment
- Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology. 2014;63(22):e57-e185.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2022;43(7):561-632.
- Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382-1394.
- Otto CM. Timing of surgery in mitral regurgitation. Heart. 2003;89(1):100-105.
- American Heart Association – Mitral Valve Regurgitation